We assessed the effects of ATRA and retinol on melanogenesis in murine B16 melanoma cells. In the present study, ATRA and retinol inhibited melanin synthesis in melanoma cells stimulated by -melanocyte stimulating hormone (-MSH) or 3-isobutyl-1-methylxanthine (IBMX). To elucidate the target points of ATRA and retinol on melanogenesis, we performed western blotting for melanogenic proteins, such as tyrosinase, tyrosinase-related protein (TRP)-1, and TRP-2. ATRA inhibited the expression of tyrosinase and TRP-1, and retinol inhibited the expression of tyrosinase, in a dose-dependent manner. Neither ATRA nor retinol inhibited TRP-2 expression. There were no differences in melanogenic protein expression between the two stimulants tested, -MSH and IBMX. Therefore, the depigmenting effect of ATRA and retinol might be due to inhibition of the signaling pathway between cAMP and tyrosinase transcription bound to tyrosinase expression. These results indicate that ATRA and retinol are candidate anti-melanogenic agents that they might be effective in hyperpigmentation disorders.
Retinol and all-trans retinoic acid (ATRA) are vitamin A derivatives that have many biological effects on differentiation and proliferation in several tissues and in the development of the embryo. [1] [2] [3] [4] [5] In the pigmentary system, ATRA has a lightening effect on hyperpigmented lesions of photodamaged human skin.
6) It causes growth arrest and differentiation of B16 melanoma cells and induces increases in the amount of protein kinase C (PKC). 7) PKC can activate tyrosinase through phosphorylation of serine residues of the cytoplasmic domain, and enhances subsequent melanin synthesis. 8 ) Nakajima et al. reported that ATRA and retinol enhance pigmentation in a concentration range of 1-100 nM. 9) In an in vivo study, ATRA increased the amount of melanocytes in mice that were exposed to ultraviolet (UV) light. 10) Human skin pigmentation is caused by melanin synthesis in UV irradiated melanocytes. Tyrosinase is a key enzyme in melanin synthesis, that can catalyze three different reactions: the hydroxylation of tyrosine to 3,4-dihydroxyphenylalanine (DOPA), the oxidation of DOPA to DOPAquinone and the oxidation of 5,6-dihydroxyindole (DHI) to indole-quinone. 11) In the absence of thiols DOPAquinone changes to DOPAchrome and then to DHI or indole 5,6-quinone 2-carboxylic acid (DHICA). There are two other main enzymes in this melanogenic pathway: tyrosinaserelated protein-2 (TRP-2; DOPAchrome tautomerase), which catalyzes the conversion of DOPAchrome to DHICA, and TRP-1 (DHICA oxidase), which catalyzes the oxidation of DHICA. [12] [13] [14] [15] [16] From the viewpoint of cellular signal transduction, there are several pathways to increase melanin production. The cAMP-mediated pathway is a well-known melanin synthesis cascade, and -MSH, prostaglandin E 2 (PGE 2 ), and adrenocorticotropic hormone (ACTH) activate the cAMP-mediated pathway. 17, 18) On the other hand, a cGMP-mediated pathway can also increase melanin production. This pathway is activated by nitric oxide (NO), which is released by keratinocytes following UV-B irradiation. 19) PKC can activate tyrosinase, as mentioned above. UV light might activate cell membrane bound phospholipase C, and augmented diacylglycerol (DAG) can activate PKC. 20) Extensive studies of the effects of ATRA on epithelial cells have been done, but the depigmenting mechanisms of vitamin A derivatives are not well known. In this study, we investigated the depigmenting effect of ATRA and retinol on murine B16 melanoma cells stimulated by cAMP elevators such as -MSH and IBMX. We found that ATRA and retinol inhibited melanin synthesis in B16 melanoma cells stimulated by -MSH or IBMX. We determined that vitamin A derivatives affected melanin synthesis through down-regulation of tyrosinase and tyrosinase-related protein expression in B16 melanoma cells.
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Materials and Methods
Cell culture. B16F1 murine melanoma cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Sigma, St. Louis, MO) supplemented with 5% heat-inactivated fetal bovine serum (FBS), 50 U/ml of penicillin, and 100 mg/ml of streptomycin at 37 C in a humidified atmosphere containing 5% CO 2 .
Cell proliferation. ATRA and retinol (Sigma) were dissolved in ethanol and added to the cell cultures at final concentrations of 5, 10, and 20 mM. The cultures were also stimulated with -MSH or IBMX (Sigma), at final concentrations of 10 nM and 50 mM respectively. After 5 d, the cells were harvested using trypsin/ethylenediaminetetraacetic acid and were counted with a Fuchs-Rosenthal cytometer.
Measurement of melanin content. Melanin contents were measured as described previously, with slight modifications.
21) The cells were treated with ATRA or retinol, followed by -MSH (10 nM) or IBMX (50 mM) for 5 d. After treatment, they were detached by a short incubation with trypsin/ethylenediaminetetraacetic acid. After precipitation, the cell pellets were photographed and solubilized in boiling 2 M NaOH for 20 min. Spectrophotometric analysis of the melanin content was performed at 405 nm.
DOPAchrome tautomerase assay. To elucidate the effect of ATRA and that of retinol on DOPAchrome tautomerase activity, assays were performed as described previously, with slight modifications. [22] [23] [24] B16 melanoma cells stimulated with -MSH or IBMX were treated with ATRA or retinol for 5 d. After treatment, the cells were collected and lysed in 0.1 M sodium phosphate buffer (pH 6.8) containing 1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 mg/ml aprotinin, and 10 mg/ml leupeptin (Sigma). A spectrophotometric assay of DOPAchrome tautomerase activity was carried out using DOPAchrome as a substrate. DOPAchrome was synthesized by mixing ice-cold L-DOPA (0.75 mg/ml) in sodium phosphate buffer (0.1 M, pH 6.8) with solid Ag 2 O (30 mg Ag 2 O/1 mg L-DOPA) for about 1 min and then filtering the mixture through Millex-GS filters (0.22 mm diameter pores, Millipore, Billerica, MA). The assay was carried out in 0.15 ml of DOPAchrome solution and an equal volume of cell extract (1 Â 10 6 cells) in a total volume of 0.3 ml. The disappearance with time of absorption at 475 nm was recorded. Phenylthiourea was included in the DOPAchrome solution at 0.1 mM final concentration to inhibit tyrosinase activity, which can interfere with the assay.
DOPA staining of gels. The DOPA staining assay was performed as described previously, with slight modifications. 25, 26) B16 melanoma cells stimulated with -MSH or IBMX were treated with ATRA or retinol for 5 d. To detect intracellular tyrosinase activity, the treated cells were collected and lysed in 0.1 M sodium phosphate buffer (pH 6.8) containing 1% Triton X-100, 1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 10% glycerol, and 0.03% bromophenol blue (BPB). The lysates (2:5 Â 10 5 cells per lane) were resolved by 7.5% SDS-polyacrylamide gel electrophoresis. Gels containing tyrosinase activity were placed in a flat-bottomed container with 200 ml of rinse buffer (0.1 M NaH 2 PO 4 , pH 6.8) and equilibrated to room temperature with gentle shaking. After 30 min, the rinse buffer was discarded and replaced with fresh buffer. After repeating the rinse procedure once more, the gels were transferred into 200 ml of a staining solution that contained the rinse buffer supplemented with 5 mM L-DOPA, and were incubated in the dark for 3 h at 37 C. Tyrosinase activity was visualized in the gels as dark, melanincontaining bands.
Western blotting. To determine the amounts of tyrosinase and tyrosinase-related proteins, western blotting analysis was performed. B16 melanoma cells stimulated with -MSH or IBMX were treated with ATRA or retinol for 5 d. After treatment, the cells were collected and lysed in cell lysis buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 6% -mercaptoethanol, 1% glycerol). Whole cell lysates (5 Â 10 4 cells per lane) were separated by 7.5% SDS-polyacrylamide gel electrophoresis, as described previously, and transferred to a nitrocellulose membrane. The membrane was incubated with 5% skim milk in phosphate-buffered saline containing 0.05% Tween-20. Tyrosinase, TRP-1, and TRP-2 were detected with rabbit polyclonal anti-tyrosinase antibody (dilution, 1:1.000), rabbit polyclonal anti-TRP-1 antibody (dilution, 1:1.000), and rabbit polyclonal anti-TRP-2 antibody (dilution 1:500) respectively, which were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The nitrocellulose membrane was further incubated with horseradish peroxidase-conjugated anti-rabbit IgG antibody at a dilution of 1:1.500. Bound antibodies were detected using an enhanced chemiluminescence kit (GE healthcare, UK) following the manufacturer's instructions. Equal loading was assessed using anti-tubulin antibody to normalize the amount of total protein.
Results

Cell proliferation
To assess the effect of vitamin A derivatives on cell proliferation, B16 melanoma cells stimulated with -MSH or IBMX were treated with different concentrations of ATRA or retinol (5-20 mM), as described in ''Materials and Methods.'' In -MSH-stimulated melanoma cells, ATRA did not show any effect on cell growth, but retinol inhibited cell growth at 20 mM (47% of the -MSH-treated B16 cells) (Fig. 1) . In IBMX-stimulated B16 melanoma cells, ATRA showed cytotoxicity at every concentration tested (approximately 50-60% of the IBMX-treated cells). Retinol showed strong inhibition of cell growth at 20 mM (21% of the IBMX treated cells).
Melanin formation
To determine the effects of ATRA and retinol on melanogenesis, B16 melanoma cells stimulated with -MSH or IBMX were cultured in the presence of ATRA or retinol at 5, 10, or 20 mM for 5 d. Treatment with ATRA at 5-20 mM yielded a significant inhibitory effect on melanin formation by B16 melanoma cells that were pre-stimulated by either -MSH (16% at 5 mM, 13% at 10 mM, and 12% at 20 mM) or IBMX (14% at 5 mM, 11% at 10 mM, and 12% at 20 mM) (Fig. 2) . Treatment with low concentrations (1-5 mM) ARTA also yielded significant inhibition. Treatment with retinol also yielded an inhibitory effect on melanogenesis in a dose-dependent manner in -MSH-stimulated melanoma cells (82% at 5 mM, 46% at 10 mM, and 18% at 20 mM). Furthermore, IBMX-stimulated melanoma cells showed stronger inhibition than -MSH-stimulated cells (43% at 5 mM, 33% at 10 mM, and 23% at 20 mM). The colors of representative cell pellets also depigmented (Fig. 3) .
DOPAchrome tautomerase (TRP-2) activity
To determine the effects of ATRA and retinol on DOPAchrome tautomerase activity, DOPAchrome tautomerase assays were performed. Treatment with ATRA or retinol had no significant effect on DOPAchrome tautomerase activity at any dose or with any stimulant (Fig. 4) .
Effect of ATRA and retinol on tyrosinase activity To determine the mechanism of the inhibitory effects of ATRA and retinol on melanogenesis more precisely, we carried out DOPA staining on polyacrylamide gels. B16 melanoma cells stimulated with -MSH or IBMX were treated with ATRA or retinol, and the cell lysates were resolved by SDS-PAGE. Upon treatment with -MSH or IBMX, B16 melanoma cells showed large increases in tyrosinase activity (Fig. 5) . ATRA significantly inhibited -MSH and IBMX-enhanced tyrosinase activity, and retinol inhibited tyrosinase activity in a dose-dependent manner. These results were similar to those of the melanin content assay (Fig. 2) .
Western blotting
To determine whether ATRA or retinol can influence melanogenic protein expression, western blotting analysis was carried out with lysates of B16 melanoma cells. When the cells were treated with -MSH or IBMX alone, a significant increase in tyrosinase protein level was observed and TRP-1 expression also increased. ATRA inhibited -MSH and IBMX-stimulated tyrosinase and TRP-1 expression, in a dose-dependent manner. Retinol also inhibited tyrosinase and TRP-1 expression. On the other hand, no significant changes in TRP-2 expression in ATRA or retinol-treated B16 melanoma cells were observed (Fig. 6) .
Discussion
In the present study, we investigated the depigmenting effect of all-trans retinoic acid (ATRA) and retinol. ATRA did not show any cytotoxicity in -MSHstimulated B16 melanoma cells, but IBMX-stimulated cells showed inhibition of cell proliferation when ATRA was added. This result indicates that IBMX affects cell proliferation only in the presence of ATRA.
ATRA and retinol inhibited melanin production in B16 melanoma cells. The colors of the cell pellets treated with vitamin A also depigmented. There were no differences between -MSH and IBMX stimulated B16 melanoma cells. Both -MSH and IBMX are major cAMP-elevating agents, but their mechanisms are quite different. -MSH can bind the melanocortin 1 receptor (MC1R) and activates adenylate cyclase, which can increase the intracellular cAMP concentration. 18 ) By inhibiting cAMP phosphodiesterase, IBMX also increases the intracellular cAMP concentration. 27) Previous reports and our current results indicate that both ATRA and retinol can inhibit melanin synthesis via the cAMP pathway. Retinol also inhibited melanin synthesis, but this depigmenting effect was not strong as that of ATRA at the same concentration.
Several well-known enzymes are involved in melanin synthesis, including tyrosinase, tyrosinase-related protein (TRP) -1, and TRP-2. 14, 28) In this study, we performed TRP-2 assays to detect the effects of vitamin A derivatives on TRP-2 activity. In addition, DOPA staining was performed to detect intracellular tyrosinase activity in B16 melanoma cells treated with the test substances. In the TRP-2 assay, we did not observe any inhibitory effects of ATRA or retinol on TRP-2 activity. In DOPA staining, ATRA inhibited both -MSH and IBMX-enhanced tyrosinase activity. Retinol also inhibited tyrosinase activity, but the inhibitory effect of retinol was weaker than that of ATRA. On the other hand, neither ATRA nor retinol (5-20 mM) had an inhibitory effect on mushroom tyrosinase in vitro (data not shown). ATRA and retinol inhibit tyrosinase activity prior to translation. To investigate the depigmenting mechanism of ATRA and retinol further, western blot analysis was carried out. B16 melanoma cells treated with -MSH or IBMX showed enhanced tyrosinase expression as compared with unstimulated cells. Both ATRA and retinol inhibited tyrosinase expression in a dose-dependent manner. ATRA inhibited TRP-1 expression, but retinol did not. Neither ATRA nor retinol influenced TRP-2 expression. There were no differences between -MSH-and IBMX-stimulated cells. Therefore, ATRA and retinol can influence tyrosinase at the 
α -MSH (10 nM) translational level and as a result down-regulate melanin production.
Kim et al. 29) have reported that piperlonguminine inhibited melanin production mediated the cAMP and cGMP pathways, but not the PKC pathway. In the present study, we did not test the inhibitory effects of ATRA or retinol on cGMP or PKC-mediated melanin production. Although it is possible that ATRA and retinol might affect the other melanogenic pathways, the main effect of ATRA and of retinol is through the cAMP-dependent melanogenic pathway. -MSH and IBMX increase the concentration of cAMP, which activates the transcription of Microphthalmia-associated transcription factor (MITF), and then MITF binds to and activates melanogenic gene promoters, which results in increased melanin synthesis. 18, 30) Previous reports have shown that ATRA enhances melanin production in B16 melanoma cells at a concentration of 1 mM (Fernandes et al.) .
31) Yoshimura et al. 32) also reported that ATRA enhanced melanin production in both murine melanocyte cell lines (melan-a) and human melanocytes at the same concentration. However, the present study indicates that ATRA significantly decreased melanogenesis in a concentration range of 1-20 mM.
The inconsistency between these results might be explained by differences in experimental conditions. Fernandes et al. investigated melanoma dendritic protrusions as a marker of melanogenesis, and they did not stimulate melanoma by -MSH. Yoshimura et al. too did not stimulate cells by cAMP inducers such as -MSH or IBMX. Inside the animal body, melanocytes produce melanin in the presence of -MSH. Hence, if one intends to test the effect of vitamin A on melanogenesis, the procedure of experiment should include co-incubation with c-AMP inducer. Previous reports that ATRA enhanced melanin production at low concentrations showed the separate effect of vitamin A, and did not clarify the physiological effects of vitamin A. Our experimental conditions are more suitable for determining the biological effects of vitamins.
Both ATRA and retinol inhibited cAMP-mediated melanin production in B16 melanoma cells. Our results indicate that the depigmenting effects of ATRA and retinol can down-regulate tyrosinase expression prior to translation, and ATRA also inhibited TRP-1 expression. Hence, ATRA and retinol are useful inhibitors of melanogenesis, and can be effective in treating hyperpigmentation disorders. Further studies of the depigmenting mechanisms of ATRA and retinol are underway.
